134054-36-7

Basic information

• Product Name: 2-[4-(4-benzhydrylpiperazin-1-yl)phenyl]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
• Synonyms: 2-[4-(4-benzhydrylpiperazin-1-yl)phenyl]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
• CAS NO: 134054-36-7
• Molecular Formula: C41H42N4O6
• Molecular Weight: 0
• Mol File: 134054-36-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-[4-(4-benzhydrylpiperazin-1-yl)phenyl]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[4-(4-benzhydrylpiperazin-1-yl)phenyl]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate(134054-36-7)
• EPA Substance Registry System: 2-[4-(4-benzhydrylpiperazin-1-yl)phenyl]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate(134054-36-7)

Safety Data

• Hazardous Substances Data: 134054-36-7(Hazardous Substances Data)

Usage

Molecular Structure

Complex, consisting of subunits including piperazine, phenyl, methyl, nitrophenyl, and dihydropyridine.

Potential Pharmacological Applications

Due to its structural similarity to certain drugs or biological ligands, it may have pharmacological relevance.

Further Analysis Required

Specific properties, uses, and potential impacts of this compound necessitate additional investigation.

Upstream product

• 116308-41-9 2-<4-(4-benzhydryl-1-piperazinyl)phenyl>ethyl acetoacetate 
• 21731-17-9 methyl 3-aminocrotonate 
• 116308-40-8 2-<4-(4-benzhydryl-1-piperazinyl)phenyl>ethyl alcohol 
• 88712-56-5 methyl (R)-5-chlorocarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate 
• 88712-56-5 methyl (R)-5-chlorocarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate 
• 76093-33-9 (R)-5-(methoxycarbonyl)-2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid 
• 76093-34-0 (+)-(S)-1,4-dihydro-2,6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)pyridine-3-carboxylic acid 

Relevant articles and documents

Use of dihydropyridine derivatives for the prophylaxis or treatment of cerebral circulation disorders

A cerebral hyperkinemic composition which containa as an effective ingredient at least a dihydropyridine derivative of the general formula wherein R1, R2 and R3, which are identical or different, independently represent an alkyl, a cycloalkyl or an

Use of dihydropyridins in cardiotonic pharmaceutical compositions

Cardiotonic pharmaceutical compositions containing a dihydropyridine derivative having a particular structure as an effective ingredient, and to methods of stimulating cardiac functions. The dihydropyridine derivatives (I) show moderate manifestation of c

Dihydropyridine derivatives for the treatment of angiospasm

A treating agent of angiospasm is disclosed, which contains, as an active ingredient, a dihydropyridine derivative represented by formula (I): wherein R1, R2 and R3 which may be the same or different, each represents an alkyl group or an alkoxyalkyl group; R4 and R5, which may be the same or different, each represents a hydrogen atom, a halogen atom, a nitro group, a halogenated alkyl group, an alkyl-sulfonyl group, a halogenated alkoxyl group, an alkylsulfinyl group, an alkyl group, an alkoxyl group, a cyano group, an alkoxycarbonyl group or an alkylthio group, provided that R4 and R5 do not simultaneously represent a hydrogen atom; X represents a vinylene group or an azomethine group; A represents an alkylene group ; and B represents -N(R6)2 or wherein R6 and R7 each represents a hydrogen atom, an alkyl group, an aralkyl group, an aryl group or a pyridyl group; Ar represents an aryl group or a pyridyl group; and n represents 0 or an integer of 1 or 2, or a pharmaceutically acceptable acid addition salt thereof. The agent exhibits high angiospasm inhibitory activity and extremely low toxicity.